More about

Biologic

News
January 13, 2020
10 min watch
Save

VIDEO: Romeo, Provencher discuss orthobiologics in orthopedics

VIDEO: Romeo, Provencher discuss orthobiologics in orthopedics

KOLOA, Hawaii — During a Facebook Live at Orthopedics Today Hawaii, Anthony A. Romeo, MD, and Matthew T. Provencher, MD, spoke about the use of orthobiologics in orthopedics.

News
January 10, 2020
3 min read
Save

2020 opens with new drug price hikes, little hope for legislation

2020 opens with new drug price hikes, little hope for legislation

Despite pressure from the Trump administration and Congress to curb rising drug costs, pharmaceutical companies — in what has become a common industry practice — have begun January 2020 by instituting a bevy of price increases.

News
November 25, 2019
1 min read
Save

Orthopedic organizations collaborate to form Biologics Alliance

The Arthroscopy Association of North America, the American Orthopaedic Society for Sports Medicine, the International Cartilage Repair Society and the Orthoregeneration Network Foundation have collaborated to form the Biologics Alliance, which will discuss all issues on musculoskeletal biologics and regenerative medicine.

News
November 21, 2019
2 min read
Save

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA

ATLANTA — Biologic DMARDs were as efficacious among patients with rheumatoid arthritis aged 60 years and older at disease onset as it was among younger patients, with comparable rates of drug maintenance and adverse event discontinuation between the two groups, according to findings presented at the 2019 ACR/ARP Annual Meeting.

News
November 14, 2019
2 min read
Save

Low clinical value in repeat latent tuberculosis tests in patients taking biologics

Low clinical value in repeat latent tuberculosis tests in patients taking biologics

Repeat, routine testing for latent tuberculosis infection among patients receiving biologics is both costly and of low clinical value, according to findings presented at the 2019 ACR/ARP Annual Meeting.

News
November 14, 2019
1 min read
Save

Biologics may be useful for ocular inflammation

SAN FRANCISCO — Only adalimumab is FDA-approved for the treatment of noninfectious intermediate and posterior uveitis and panuveitis; however, other biologics hold promise for the treatment of ocular inflammation, according to a presentation at Cornea Subspecialty Day at the American Academy of Ophthalmology annual meeting.

News
September 30, 2019
1 min read
Save

Ocugen enters partnership with CanSinoBIO, completes Histogenics merger

Ocugen announced a strategic partnership with CanSino Biologics for gene therapy candidates and also the completion of its merger with Histogenics.

News
September 12, 2019
2 min read
Save

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate

Patients with rheumatoid arthritis who achieve low disease activity with tofacitinib plus methotrexate can safely withdraw methotrexate without fear of worsening disease activity, according to findings published in The Lancet Rheumatology.

News
August 06, 2019
4 min read
Save

Joint guidelines explore best practices in NB-UVB therapy for psoriasis

Based on the available literature, the American Academy of Dermatology and the National Psoriasis Foundation published joint guidelines on ultraviolet light-based therapies for the treatment of psoriasis.

View more